G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,587,000 | -77.5% | 191,665 | -72.2% | 0.00% | -50.0% |
| Q4 2021 | $7,048,000 | -21.1% | 690,270 | +3.7% | 0.00% | -33.3% |
| Q3 2021 | $8,932,000 | -54.1% | 665,560 | -24.9% | 0.00% | -50.0% |
| Q2 2021 | $19,452,000 | +17.7% | 886,640 | +29.1% | 0.01% | +20.0% |
| Q1 2021 | $16,520,000 | +34.8% | 686,606 | +0.8% | 0.01% | +25.0% |
| Q4 2020 | $12,254,000 | +177.1% | 681,201 | +77.9% | 0.00% | +100.0% |
| Q3 2020 | $4,423,000 | +8.7% | 382,999 | +128.3% | 0.00% | 0.0% |
| Q2 2020 | $4,070,000 | +160.4% | 167,756 | +18.2% | 0.00% | +100.0% |
| Q1 2020 | $1,563,000 | -55.0% | 141,869 | +7.8% | 0.00% | 0.0% |
| Q4 2019 | $3,476,000 | +14.4% | 131,547 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $3,039,000 | -13.3% | 133,388 | +16.7% | 0.00% | 0.0% |
| Q2 2019 | $3,505,000 | – | 114,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |